The clinical diagnostic utility of transcranial magnetic stimulation: Report of an IFCN committee

  title={The clinical diagnostic utility of transcranial magnetic stimulation: Report of an IFCN committee},
  author={Robert Chen and Didier P. Cros and Antonio Curr{\`a} and V. Lazzaro and J. P. Lefaucheur and Michel Roland Magistris and Kerry R Mills and Kai Michael R{\"o}sler and William Triggs and Yoshikazu Ugawa and Ulf Ziemann},
  journal={Clinical Neurophysiology},

Figures and Tables from this paper

Superficial brain stimulation in multiple sclerosis.

Transcranial Magnetic Stimulation and Transcranial Electrical Stimulation in Horses.

Transcranial Magnetic Stimulation of the Motor Cortex Correlates With Objective Clinical Measures in Patients With Cervical Spondylotic Myelopathy

CMCT as measured by transcranial magnetic stimulation is a responsive objective assessment of CSM and can be used to monitor disease severity and neurological function before and after surgical intervention.

Quantitative assessment of myelopathy patients using motor evoked potentials produced by transcranial magnetic stimulation

MEP abnormalities are useful for an electrophysiological evaluation of myelopathy patients and may be effective parameters in spinal pathology for deciding the operative treatment.

The Role of Transcranial Magnetic Stimulation as a Diagnostic Tool for Multiple Sclerosis

It is speculated that TMS may be more effective in identifying disease progression that leads to long-term disability, compared to standard surrogate markers, due to the fact that it represents a direct measure of synaptic transmission(s) in MS.

Motor disability in patients with multiple sclerosis: transcranial magnetic stimulation study

TMS yields objective data to evaluate clinical disability and its parameters correlated well with EDSS, whereas motor evoked potential (MEP) amplitude not.


Single-pulse TMS is a valuable study to investigate central motor dysfunction in PD and CMCT measurement of the median nerve or any nerve in the upper limb is a potential marker for the evaluation of the severity of PD; especially in the facilitated state.

Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.




Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS.

  • J. PougetS. TréfouretS. Attarian
  • Biology, Psychology
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
  • 2000
Transcranial magnetic stimulation is a widely available, painless and safe technique with a good sensitivity that can visualize both corticospinal and corticobulbar tract abnormalities and the sensitivity can be improved further by taking into account the several MEP parameters, including latency and cortical silent period decreased duration.

Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in Amyotrophic Lateral Sclerosis (ALS)

The results indicate the early and in most cases subclinical corticobulbar tract involvement of the central motor pathways to the orofacial muscles and tongue in ALS is indicated.

Transcranial magnetic stimulation techniques in clinical investigation

TMS applications have an important place among the investigative tools to study patients with motor disorders and give information on the pathophysiology of the processes underlying the various clinical conditions.

Transcranial magnetic stimulation in lower motor neuron diseases

Transcranial magnetic stimulation in patients with cerebellar stroke.

It is demonstrated that the cerebellum dysfunction plays a role in the abnormalities of CMCT elicited by TMS, and electrophysiological improvement closely related to clinical cerebellar recovery rate.

Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease

TMS provides a sensitive means for the assessment and monitoring of excitatory and inhibitory upper motor neuron function in motor neuron disease and shows progression of abnormalities, including progressive inexcitability of central motor pathways and loss of the normal inhibitory cortical stimulation silent period.

Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes

Data suggest impairment of callosal integrity in patients with CBD and PSP, and iSP measurements may be a useful clinical neurophysiologic test in differential diagnosis of patients with parkinsonian syndromes.

Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation

The combination of central motor latencies and transcallosal inhibition evoked by transcranial magnetic stimulation yields objective data to estimate disease progression in MS as assessed by the EDSS.